Wolverine Trading, LLC Sangamo Therapeutics, Inc Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.32 - $1.1 $6,752 - $23,210	21,100 New	21,100 $18,000
Q1 2024 May 15, 2024	BUY	$0.42 - $1.38 $4,284 - $14,075	10,200 New	10,200 $6,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $3,645 - $5,485	-500 Reduced 4.67%	10,200 $80,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $30,634 - $40,834	-3,400 Reduced 24.11%	10,700 $98,000
Q2 2021 Aug 06, 2021	BUY	$10.17 - $12.64 $30,510 - $37,920	3,000 Added 27.03%	14,100 $165,000
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $553,792 - $867,845	-50,900 Reduced 82.1%	11,100 $130,000
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $109,837 - $216,342	11,900 Added 23.75%	62,000 $1.05 Million
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $118,188 - $157,248	-12,600 Reduced 20.1%	50,100 $495,000
Q2 2020 Aug 13, 2020	SELL	$6.21 - $11.83 $44,712 - $85,176	-7,200 Reduced 10.3%	62,700 $550,000
Q1 2020 May 11, 2020	SELL	$5.05 - $8.85 $295,425 - $517,725	-58,500 Reduced 45.56%	69,900 $454,000
Q4 2019 Feb 12, 2020	BUY	$8.03 - $11.7 $152,570 - $222,300	19,000 Added 17.37%	128,400 $1.05 Million
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $57,920 - $78,208	-6,400 Reduced 5.53%	109,400 $1.01 Million
Q2 2019 Aug 20, 2019	SELL	$8.75 - $13.03 $388,500 - $578,532	-44,400 Reduced 27.72%	115,800 $1.25 Million
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $457,024 - $758,352	-59,200 Reduced 26.98%	160,200 $1.53 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $524,952 - $916,320	55,200 Added 33.62%	219,400 $2.38 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $644,670 - $941,070	49,400 Added 43.03%	164,200 $2.78 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $1.22 Million - $1.93 Million	-73,100 Reduced 38.9%	114,800 $2.18 Million
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $624,080 - $933,430	53,800 Added 40.12%	187,900 $3.08 Million
Q3 2017 Nov 15, 2017	BUY	$8.4 - $15.0 $1.13 Million - $2.01 Million	134,100	134,100 $2.01 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$21.2 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$10.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.29 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.13 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.57 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $171M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account